The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 29, 2022
Filed:
Feb. 07, 2013
Applicant:
Access to Advanced Health Institute, Seattle, WA (US);
Inventors:
Christopher Fox, Sumner, WA (US);
Steven G. Reed, Bellevue, WA (US);
Susan Baldwin, Seattle, WA (US);
Thomas Vedvick, Federal Way, WA (US);
Assignee:
ACCESS TO ADVANCED HEALTH INSTITUTE, Seattle, WA (US);
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/113 (2006.01); A61K 39/39 (2006.01); A61K 39/015 (2006.01); A61K 39/12 (2006.01); A61K 9/107 (2006.01); A61K 47/06 (2006.01); A61K 39/00 (2006.01); A61K 47/24 (2006.01); A61K 47/26 (2006.01);
U.S. Cl.
CPC ...
A61K 9/113 (2013.01); A61K 9/107 (2013.01); A61K 39/00 (2013.01); A61K 39/015 (2013.01); A61K 39/12 (2013.01); A61K 39/39 (2013.01); A61K 47/06 (2013.01); A61K 47/24 (2013.01); A61K 47/26 (2013.01); A61K 2039/55566 (2013.01); A61K 2039/55572 (2013.01); C12N 2760/16134 (2013.01); C12N 2760/16234 (2013.01);
Abstract
Formulations and methods, including vaccines and pharmaceutical compositions for inducing or enhancing an immune response are disclosed. The formulations generally comprise a TLR4 agonist and a metabolizable oil at a concentration of about 0.01%-1% v/v, wherein the hydrophobic:lipophilic balance (HLB) of the emulsion is greater than about 9.